Monday, 08 October 2007
Note,…. this timeline would benefit from some updates.
2001 October 12. Intellectual Property, innovation and international trade agreements. Wizards of OS. Discussion of R&D Treaty.
2001 December 20. Can we create a global trade framework for health care R&D that puts patients first? Presented at the Fifth International Conference on Home and Community Care for Persons Living with HIV/AIDS. Chaing Mai, Thailand.
2002 February 11. Can we create a global trade framework for health care R&D that puts patients first?
2002 March 10. Can we create a global trade framework for health care R&D that puts patients first? Madison Wisconsin.
2002 September 18. Ottrott-le-Haut, France, Hubbard and Love present Radical IP scenarios to Aventis meeting on pharamceutical scenarios.
2002 November 1. How to frame a global trade agreement that promotes R&D and does not undermine lower prices in countries with less ability to pay. The Trans Atlantic Consumer Dialogue (TACD) Committee on Intellectual Property meeting on the Impact of Intellectual Property Rules on Consumers of Health Care Services.
2002 December 3. James Love. PPT presentation given at The Drugs for Neglected Diseases (DND) Working Group, in Rio de Janerio, Brazil. The Benifits of a Treaty on R&D.
2003 February 28. How can we address access, and fund R&D? Next steps in the campaign for access to essential medicines. Mailman School of Public Health, Columbia University, New York, NY
2003 March 20. New Intellectual Property Regimes and New Business Models for Funding R&D, The Human Genome and Africa, Stellenbosch, South Africa
2003 April 29. Basis for a treaty on R&D. CPTech, MSF, Oxfam Meeting on global framework for supporting health research and development (R&D) in areas of market and public policy failure. Geneva.
2003 May 27. From TRIPS to RIPS: A better Trade Framework to support Innovation in Medical Technologies, Agence nationale de recherches sur le sida/Institute d’ économie publique. Workshop on Economic issues related to access to HIV/AIDS care in developing countries Université de la Méditerranée, Marseille, France
2003 June 14. Tim Hubbard and James Love in the New Scientist. Medicines without barriers.
2003 June 24. Tim Hubbard and James Love. Paper presented at the Meeting on The Role of Generics and Local Industry in Attaining the Millennium Development Goals (MDGs) in Pharmaceuticals and Vaccines held at the World Bank. An Agenda for Research and Development.
2003 September 24-29. Global Dialogues on IP: Public Health & IP/Collective Management of IP, Rockefeller Foundation Bellagio Study and Conference Center.
2003 November 12. Two Steps for Equitable Access to Intellectual Property.
2003 November 17. A better trade framework to support innovation in health care technologies, The Aventis/Marseille Proposal, James Love, APHA.
2003 December 4. Paper presentend by James Love at Columbia University's Workshop on Access to Medicines and the Financing of Innovations in Heath Care. A New Trade Framework for Global Healthcare R&D.
2004 February 2. Essay by James Love and Tim Hubbard published in the PLoS Biology. A New Trade Framework for Global Healthcare R&D.
2004 March 4. Op-ed by James Love and Tim Hubbard published in the Guardian. We're Patently Going Mad: Lifesaving drugs must be developed differently – for all our sakes. Here is James V. Delong's rather rambling attack on the Guardian article, which links quite a few different issues, proposals and movements into one.
2005 January 26. Rep. Sanders introduced H.R. 417 – The Medical Innovation Prize Fund Act, in the 109th Congress.
2005 June 8. Understanding the Medical R&D Treaty Proposal. MSF meeting on ensuring innovation for neglected diseases,
2005 September 9. Australia presentation. New Paradigms in International Trade for Knowledge Goods
2005 September 24. Determining the value of a pharmaceutical invention under HR 417, the Medical Innovation Prize Fund, International Seminar: Contributions to the Development Agenda on Intellectual Property Rights. UNU-INTECH, Maastricht, The Netherlands.
2005 October 1. Determining the value of a pharmaceutical invention under HR 417, the Medical Innovation Prize Fund. Montreal.
2006 May. James Love. Bulletin of the World Health Organization. 84 (5). Drug development incentives to improve access to essential medicines.
2006 September 25. Stimulating medical R&D when inventions enter the public domain, CIPP Workshop on Intellectual Property, Biotechnology Capacity and Development. Buenos Aires.